Neil Baladkar
Vice President of Investor Relations
Replay available
Kestra Medical Technologies, Ltd. (KMTS) Q3 2025 Earnings Call
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) Q3 2025 earnings conference call, held 2025-04-14. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Brian Webster
President and Chief Executive Officer
Vasim Meboob
Chief Financial Officer
Travis Steed
Analyst, Bank of America Securities
Matthew O'Brien
Analyst, Piper Sandler
Larry Beagleson
Analyst, Wells Fargo
David Roman
Analyst, Goldman Sachs
Rick Weiss
Analyst, Stifel
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Kestra Medical Technologies, Ltd..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.275 good afternoon and welcome to the castra medical technologies third quarter 00:00:05.275 -- 00:00:10.280 fiscal 2025 earnings conference call this conference call 00:00:10.280 -- 00:00:13.202 is being recorded for replay purposes 00:00:13.202 -- 00:00:18.226 we will be facilitating a question and answer session following prepared remarks 00:00:18.226 -- 00:00:19.828 from management 00:00:19.828 -- 00:00:24.932 at this time all participants are in a listen only mode i would now like to turn 00:00:24.932 -- 00:00:30.306 the call over to neil baladkar vice president of investor 00:00:30.306 -- 00:00:33.111 relations. Please go ahead. 00:00:33.111 -- 00:00:38.380 Thanks, Lateef. Thank you all for joining Kestra's third quarter fiscal 2025 00:00:38.380 -- 00:00:44.010 earnings call. With me today are Brian Webster, President and Chief Executive Officer, 00:00:44.010 -- 00:00:47.776 and Vasim Meboob, Chief Financial Officer. 00:00:47.776 -- 00:00:51.944 This call includes forward-looking statements within the meaning of the Private Securities 00:00:51.944 -- 00:00:54.959 Litigation Reform Act of 1995. 00:00:54.959 -- 00:00:59.486 Statements made on this call that do not relate to matters of historical fact should 00:00:59.486 -- 00:01:04.193 be considered forward-looking statements. These statements are based on Kestra's current 00:01:04.193 -- 00:01:09.981 expectations, forecasts, and assumptions, which are subject to inherent uncertainties, 00:01:09.981 -- 00:01:13.446 risks, and assumptions that are difficult to predict. 00:01:13.446 -- 00:01:18.674 Actual outcomes and results could differ materially from any results, performance, 00:01:18.674 -- 00:01:23.541 or achievements expressed or implied by the forward-looking statements due t...